Search results :

Dexrazoxane

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: V03AF02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7
Alopecia 94% - 100% 97% - 98% x x x x x x
Nausea 51% - 82% 60% - 84% x x x x x x
Malaise 48% - 62% 55% - 58% x x x x
Fatigue 48% - 61% 55% - 58% x x x x x x
Vomiting 42% - 63% 49% - 72% x x x x x x
Anorexia 27% - 50% 38% - 47% x x x x x
Stomatitis 26% - 36% 28% - 41% x x x x x x
Body temperature increased 18% - 35% 18% - 29% x x x x x x
Infection 19% - 23% 18% - 21% x x x x x x
Diarrhoea 7% - 22% 7% - 24% x x x x x x
Sepsis 9% - 31% 9% - 14% x x x x
Neurotoxicity 5% - 17% 5% - 13% x x x x
Pain 0% - 13% 0% - 3% x x x x x
Dysphagia 0% - 8% 5% - 10% x x x x
Phlebitis 3% - 6% 3% - 5% x x x x x
Oesophagitis 3% - 6% 4% - 7% x x x x
Erythema 2% - 5% 2% - 4% x x x x
Extravasation 1% - 3% 1% - 2% x x x
Haemorrhage 1% - 3% 1% - 2% x x x x
Urticaria 0% - 4% 0% - 2% x x x x
Cardiac failure congestive 1% x
Abdominal pain x
Agranulocytosis x x x x x
Anaemia x
Mental disorder x
Breast disorder x
Neoplasm malignant x x x
Connective tissue disorder x x
Constipation x
Cough x
Depression x
Dizziness x x
Dyspnoea x x
Gastrointestinal disorder x x
Headache x
Cardiac disorder x
Leukopenia x x x x
Mediastinal disorder x x
Nervous system disorder x x
Neutropenia x x
Pneumonia x x
Pruritus x
Syncope x
Thrombocytopenia x x x x x x x
Tremor x
Angiopathy x x
Weight decreased x
Dry mouth x
Oedema peripheral x x
Creatinine increased x
Injection site swelling x
Injection site reaction x
Lactic dehydrogenase activity increased 0% x
Injection site pain x x
Phosphatase alkaline increased 0% x
Aspartate aminotransferase increased x
Alanine aminotransferase increased x
Haemoglobin decreased 0% x
Malnutrition x x
Unspecified disorder of skin and subcutaneous tissue x
Myalgia x
Decreased appetite x
Disease progression x x
Sensory loss x
Blood bilirubin increased 0% x
Platelet count decreased 0% x
Postoperative infection x x
Injection site induration x
Injection site phlebitis x x
Ca++ increased x
Febrile neutropenia x x
White blood cell count decreased x
Infestation NOS x x
Blood and lymphatic system disorders x x
Injection site erythema x
Venous thrombosis limb x
Myelosuppression x x
Sodium decreased x
Cardiotoxicity x x
Infusion site burning x
Insomnia x
Wound complication x
Neutropenic infection x
Thrombophlebitis superficial x
Somnolence x
Vaginal haemorrhage x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

dexrazoxane for injection / Zinecard

Side effects:5
Source:FDA

Dexrazoxane

Side effects:23
Source:BC Cancer

dexrazoxane / ZINECARD

Side effects:24
Source:FDA

DEXRAZOXANE

Side effects:26
Source:FDA Structured Product Label

DEXRAZOXANE

Side effects:26
Source:FDA Structured Product Label

dexrazoxane / dexrazoxane hydrochloride

Side effects:46
Source:EMA

DEXRAZOXANE HYDROCHLORIDE / TOTECT

Side effects:49
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label